LC method for the determination of oxcarbazepine in pharmaceutical preparations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 31, Issue 1, 2003, Pages 57-62

  Qi, M L ^a   Wang, P ^b   Wang, L J ^b   Fu, R N ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

^b Shenyang Pharmtech Inst P   (China)

Author keywords

HPLC; Oxcarbazepine; Tablet formulation

Indexed keywords

ACETONITRILE; OXCARBAZEPINE; POTASSIUM DIHYDROGEN PHOSPHATE; SODIUM DIHYDROGEN PHOSPHATE; WATER;

ACCURACY; ARTICLE; DRUG ABSORPTION; DRUG DETERMINATION; DRUG MONITORING; DRUG SELECTIVITY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LINEAR SYSTEM; PRIORITY JOURNAL; TABLET FORMULATION; VALIDATION PROCESS;

ANTICONVULSANTS; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; REPRODUCIBILITY OF RESULTS; TABLETS;

EID: 0242432607     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00602-7     Document Type: Article

References (10)

1. Grant S.M., Faulds D. Drugs. 43:1992;873-888.
2. Fraser A.D. Clin. Biochem. 29:1996;97-110.
3. Shorvon S. Seizure. 9:2000;75-79.
4. Kalis M.M., Huff N.A. Clin. Ther. 23:2001;680-700.
5. Hartley R., Green M., Lucock M.D., Ryan S., Forsythe W.I. Biomed. Chromatogr. 5:1991;212-215.
6. Rouan M.C., Decherf M., Le Clanche V., Lecaillon J.B., Godbillon J. J. Chromatogr. B Biomed. Appl. 658:1994;167-172.
7. Matar K.M., Nicholls P.J., al-Hassan M.I., Tekle A. J. Clin. Pharm. Ther. 20:1995;229-234.
8. Pienimaki P., Fuchs S., Isojarvi J. J. Pharm. Biomed. Anal. 673:1995;97-105.
9. Bhatti M.M., Hanson G.D., Schultz L. J. Pharm. Biomed. Anal. 16:1998;1233-1240.
10. Matar K.M., Nicholls P.J., Tekle A. Ther. Drug Monit. 21:1999;559-566.